[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-001", "question": "A 68-year-old man with a history of severe COPD (FEV1 35% predicted) and chronic hypercapnia (baseline PaCO2 55 mmHg) presents with acute-on-chronic hypercapnic respiratory failure requiring non-invasive ventilation. After 48 hours of improvement, his arterial blood gas shows pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg on 2 L/min nasal cannula. He is alert and comfortable. The next most appropriate step in management is:", "options": ["Gradually wean and discontinue supplemental oxygen to target a PaO2 of 55-60 mmHg", "Continue current oxygen therapy and plan for discharge home with home oxygen", "Increase oxygen flow to achieve a PaO2 > 88 mmHg", "Obtain a venous blood gas to confirm the arterial values", "Initiate acetazolamide 250 mg twice daily to accelerate renal compensation"], "answer": "A", "answer_index": 0, "explanation": "In patients with chronic hypercapnia, the hypoxic drive is a primary respiratory stimulus. Over-oxygenation can suppress this drive, leading to worsening hypercapnia and acidosis. The target PaO2 is 55-60 mmHg or SpO2 88-92%, which provides adequate oxygenation while minimizing the risk of CO2 retention. Increasing oxygen (C) is dangerous, and acetazolamide (E) is not indicated in acute-on-chronic respiratory failure as it can worsen acidosis by inhibiting compensatory metabolic alkalosis.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with severe COPD and chronic hypercapnia who has recovered from acute respiratory failure. He is currently hyperoxic (PaO2 85 mmHg) on 2 L/min nasal cannula. Standard management for patients with chronic hypercapnia involves titrating oxygen to a target SpO2 of 88–92% (corresponding roughly to a PaO2 of 55–70 mmHg) to avoid worsening hypercapnia (via V/Q mismatch, Haldane effect, and reduced respiratory drive). Option A is the only choice that reflects the necessary de-escalation of oxygen therapy. Although the specific target range in Option A (55–60 mmHg) is on the lower end of the acceptable spectrum (often 60–70 mmHg is preferred), it corresponds to SpO2 ~88–90% and is safe, whereas maintaining PaO2 85 mmHg (Option B) or increasing it (Option C) is inappropriate. Option E is incorrect because the pH is normalized (7.36); acetazolamide is typically reserved for post-hypercapnic metabolic alkalosis with high pH. The item is logically sound and medically defensible.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with severe COPD and chronic hypercapnia who has recovered from acute respiratory failure. He is currently hyperoxic (PaO2 85 mmHg) on 2 L/min nasal cannula. Standard management for patients with chronic hypercapnia involves titrating oxygen to a target SpO2 of 88–92% (corresponding roughly to a PaO2 of 55–70 mmHg) to avoid worsening hypercapnia (via V/Q mismatch, Haldane effect, and reduced respiratory drive). Option A is the only choice that reflects the necessary de-escalation of oxygen therapy. Although the specific target range in Option A (55–60 mmHg) is on the lower end of the acceptable spectrum (often 60–70 mmHg is preferred), it corresponds to SpO2 ~88–90% and is safe, whereas maintaining PaO2 85 mmHg (Option B) or increasing it (Option C) is inappropriate. Option E is incorrect because the pH is normalized (7.36); acetazolamide is typically reserved for post-hypercapnic metabolic alkalosis with high pH. The item is logically sound and medically defensible.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-002", "question": "A 45-year-old woman with a history of recurrent calcium oxalate kidney stones presents with acute pancreatitis. Lipase is 1200 U/L, calcium 11.8 mg/dL, PTH 85 pg/mL (normal 10-65). She is not on lithium or thiazides. A pancreatic protocol CT shows diffuse gland enlargement but no necrosis or ductal dilation. The most likely underlying etiology of her pancreatitis is:", "options": ["Primary hyperparathyroidism due to parathyroid adenoma", "Autoimmune pancreatitis (IgG4-related disease)", "Hereditary pancreatitis due to PRSS1 mutation", "Hypertriglyceridemia-induced pancreatitis", "Pancreatitis secondary to a gastrinoma (Zollinger-Ellison syndrome)"], "answer": "A", "answer_index": 0, "explanation": "The triad of hypercalcemia, elevated PTH, and recurrent calcium oxalate stones is classic for primary hyperparathyroidism. Hypercalcemia is a known, though uncommon, cause of pancreatitis. The elevated PTH confirms primary hyperparathyroidism, not secondary causes. While hypertriglyceridemia (D) can cause pancreatitis, it doesn't explain the hypercalcemia and elevated PTH. Gastrinoma (E) is associated with ulcers and diarrhea, not typically hypercalcemia and stones.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of primary hyperparathyroidism (PHPT) characterized by hypercalcemia (11.8 mg/dL) and inappropriately elevated PTH (85 pg/mL) in the setting of recurrent calcium oxalate stones. Hypercalcemia is a well-established metabolic cause of acute pancreatitis. Option A is the only choice that unifies the renal stones, hypercalcemia, elevated PTH, and pancreatitis. While \\\"diffuse gland enlargement\\\" is a feature of autoimmune pancreatitis (Option B), it is also consistent with generalized edema in acute pancreatitis of any cause; crucially, Option B cannot explain the hypercalcemia or elevated PTH. Options C, D, and E fail to account for the specific metabolic profile (high Calcium/PTH). The item is logically sound, medically accurate, and the key is uniquely defensible.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of primary hyperparathyroidism (PHPT) characterized by hypercalcemia (11.8 mg/dL) and inappropriately elevated PTH (85 pg/mL) in the setting of recurrent calcium oxalate stones. Hypercalcemia is a well-established metabolic cause of acute pancreatitis. Option A is the only choice that unifies the renal stones, hypercalcemia, elevated PTH, and pancreatitis. While \"diffuse gland enlargement\" is a feature of autoimmune pancreatitis (Option B), it is also consistent with generalized edema in acute pancreatitis of any cause; crucially, Option B cannot explain the hypercalcemia or elevated PTH. Options C, D, and E fail to account for the specific metabolic profile (high Calcium/PTH). The item is logically sound, medically accurate, and the key is uniquely defensible.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-003", "question": "A 32-year-old woman presents with 3 weeks of progressive dyspnea and fatigue. Echocardiogram shows a large pericardial effusion with diastolic right atrial and right ventricular collapse. Right heart catheterization reveals equalization of diastolic pressures (RA 18, RV 18, PA 18/20, PCWP 18 mmHg). After pericardiocentesis of 800 mL of serosanguinous fluid, hemodynamics improve. Cytology is negative. Two days later, she develops recurrent dyspnea. Repeat echo shows reaccumulation of the effusion. The most appropriate definitive management is:", "options": ["Repeat pericardiocentesis and initiate colchicine", "Surgical creation of a pericardial window via subxiphoid approach", "Initiation of high-dose prednisone for suspected autoimmune pericarditis", "Pericardiectomy via left thoracotomy", "Intrapericardial instillation of bleomycin"], "answer": "B", "answer_index": 1, "explanation": "Recurrent symptomatic pericardial effusion with tamponade physiology, especially when cytology is negative (ruling out malignancy requiring specific therapy), is a clear indication for a definitive surgical procedure to prevent reaccumulation. A surgical pericardial window (subxiphoid or video-assisted) allows for drainage and biopsy. Pericardiectomy (D) is reserved for constrictive pericarditis. Steroids (C) are for inflammatory causes but are not definitive for recurrent effusion. Intrapericardial chemotherapy (E) is for malignant effusions.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid)\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a patient with recurrent cardiac tamponade (dyspnea, hypotension implied by improvement, echo findings, pressure equalization) occurring rapidly (2 days) after initial pericardiocentesis. The negative cytology leaves the etiology undiagnosed. The key discriminating factors are the recurrence and the need for tissue diagnosis. Option B (pericardial window) is the standard of care for recurrent symptomatic effusions; it provides a route for continuous drainage to prevent re-tamponade and allows for pericardial biopsy to establish an etiology. Option A is incorrect because the effusion reaccumulated rapidly after the first tap, making simple repetition inadequate. Option D (pericardiectomy) is overly invasive as a next step and is reserved for constrictive pericarditis or cases refractory to a window. Options C and E require a specific diagnosis (autoimmune or malignant) which is not yet established. \\n\\nNote: The hemodynamic data lists PA pressure as \\\"18/20\\\", which is technically impossible (diastolic > systolic) or a typo for 20/18. However, the explicit statement of \\\"equalization of diastolic pressures\\\" and the clinical context make the diagnosis of tamponade unambiguous despite this minor error.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid)\nVerdict on keyed answer: Correct best\n\nThe vignette describes a patient with recurrent cardiac tamponade (dyspnea, hypotension implied by improvement, echo findings, pressure equalization) occurring rapidly (2 days) after initial pericardiocentesis. The negative cytology leaves the etiology undiagnosed. The key discriminating factors are the recurrence and the need for tissue diagnosis. Option B (pericardial window) is the standard of care for recurrent symptomatic effusions; it provides a route for continuous drainage to prevent re-tamponade and allows for pericardial biopsy to establish an etiology. Option A is incorrect because the effusion reaccumulated rapidly after the first tap, making simple repetition inadequate. Option D (pericardiectomy) is overly invasive as a next step and is reserved for constrictive pericarditis or cases refractory to a window. Options C and E require a specific diagnosis (autoimmune or malignant) which is not yet established. \n\nNote: The hemodynamic data lists PA pressure as \"18/20\", which is technically impossible (diastolic > systolic) or a typo for 20/18. However, the explicit statement of \"equalization of diastolic pressures\" and the clinical context make the diagnosis of tamponade unambiguous despite this minor error.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-004", "question": "A 70-year-old man with atrial fibrillation on apixaban (non-valvular) presents with acute onset of right-sided weakness and aphasia 4 hours after symptom onset. NIHSS is 15. CT head shows no hemorrhage. He is not a candidate for IV tPA due to anticoagulation. CT angiography shows a left M1 MCA occlusion. The most appropriate acute intervention is:", "options": ["Administer IV tPA after checking an INR and anti-Xa level", "Proceed directly to mechanical thrombectomy without thrombolysis", "Administer IV protamine to reverse apixaban, then give IV tPA", "Administer andexanet alfa, then give IV tPA", "Initiate IV heparin drip and observe for neurological improvement"], "answer": "B", "answer_index": 1, "explanation": "For patients with acute ischemic stroke and large vessel occlusion (LVO) who are not candidates for IV tPA, mechanical thrombectomy is the standard of care if performed within 24 hours of last known well and meeting other criteria (like NIHSS ≥6). Direct thrombectomy is non-inferior to bridging therapy (tPA + thrombectomy). Reversing anticoagulation to give tPA (C, D) delays definitive therapy and adds bleeding risk. Giving tPA on top of therapeutic anticoagulation (A) is contraindicated.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with an acute ischemic stroke due to a large vessel occlusion (LVO) of the left M1 MCA. The patient presents within the 6-hour window for mechanical thrombectomy (MT). The stem explicitly states the patient is ineligible for IV tPA due to apixaban use, which aligns with guidelines (tPA is contraindicated if a DOAC was taken <48 hours ago or labs are abnormal). Therefore, the standard of care is to proceed directly to mechanical thrombectomy (Option B). Option A is incorrect because tPA is contraindicated. Option C is incorrect because protamine does not reverse apixaban (it reverses heparin). Option D is incorrect because reversing a DOAC to administer tPA is not standard practice; it delays definitive endovascular therapy and carries unproven safety/efficacy risks compared to direct MT. Option E is incorrect as anticoagulation is not the acute treatment for ischemic stroke. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with an acute ischemic stroke due to a large vessel occlusion (LVO) of the left M1 MCA. The patient presents within the 6-hour window for mechanical thrombectomy (MT). The stem explicitly states the patient is ineligible for IV tPA due to apixaban use, which aligns with guidelines (tPA is contraindicated if a DOAC was taken <48 hours ago or labs are abnormal). Therefore, the standard of care is to proceed directly to mechanical thrombectomy (Option B). Option A is incorrect because tPA is contraindicated. Option C is incorrect because protamine does not reverse apixaban (it reverses heparin). Option D is incorrect because reversing a DOAC to administer tPA is not standard practice; it delays definitive endovascular therapy and carries unproven safety/efficacy risks compared to direct MT. Option E is incorrect as anticoagulation is not the acute treatment for ischemic stroke. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-005", "question": "A 55-year-old man with alcoholic cirrhosis (Child-Pugh B) is admitted with hepatic encephalopathy. He is started on lactulose. On day 3, he develops acute kidney injury. Serum sodium is 122 mEq/L (down from 128 on admission), creatinine 2.4 mg/dL (baseline 0.9), and he is clinically envolemic. Urine sodium is <10 mEq/L, urine osmolality 550 mOsm/kg. The most likely cause of his hyponatremia is:", "options": ["Syndrome of inappropriate antidiuretic hormone secretion (SIADH)", "Acute tubular necrosis from sepsis", "Hepatorenal syndrome type 1", "Pseudohyponatremia from hypertriglyceridemia", "Hyponatremia due to lactulose-induced diarrhea"], "answer": "E", "answer_index": 4, "explanation": "Lactulose causes an osmotic diarrhea, leading to loss of sodium and water, but relatively more water loss, resulting in hypertonic hyponatremia. The clinical picture (envolemic, high urine osmolality, low urine sodium) is consistent with volume depletion from GI losses, not SIADH (which has inappropriately high urine sodium). Hepatorenal syndrome (C) is characterized by low urine sodium but typically occurs in the setting of avid sodium retention and ascites, not acute diarrhea. ATN (B) would have high urine sodium.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is medically invalid due to fundamental physiological errors in the keyed answer and rationale. The key (E) attributes hyponatremia to lactulose-induced osmotic diarrhea, claiming it causes \\\"relatively more water loss.\\\" Medically, the loss of free water in excess of sodium results in hypernatremia, not hyponatremia. While lactulose can indirectly cause hyponatremia via hypovolemia-induced ADH release (if accompanied by free water intake), the explanation explicitly describes a mechanism of water loss leading to hyponatremia, which is physically impossible. Furthermore, the explanation incorrectly labels this \\\"hypertonic hyponatremia,\\\" a term reserved for translocational hyponatremia (e.g., hyperglycemia), not fluid loss. Additionally, the stem describes the patient as \\\"clinically envolemic\\\" (likely typo for euvolemic), contradicting the urine indices (Na < 10) and the explanation's assertion of \\\"volume depletion.\\\" Option C (HRS) is a plausible distractor but is a diagnosis of exclusion; normally, one must rule out prerenal causes (like lactulose dehydration) first. Since the keyed answer relies on false pathophysiology and the alternative is not definitively established, no option is defensible.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is medically invalid due to fundamental physiological errors in the keyed answer and rationale. The key (E) attributes hyponatremia to lactulose-induced osmotic diarrhea, claiming it causes \"relatively more water loss.\" Medically, the loss of free water in excess of sodium results in hypernatremia, not hyponatremia. While lactulose can indirectly cause hyponatremia via hypovolemia-induced ADH release (if accompanied by free water intake), the explanation explicitly describes a mechanism of water loss leading to hyponatremia, which is physically impossible. Furthermore, the explanation incorrectly labels this \"hypertonic hyponatremia,\" a term reserved for translocational hyponatremia (e.g., hyperglycemia), not fluid loss. Additionally, the stem describes the patient as \"clinically envolemic\" (likely typo for euvolemic), contradicting the urine indices (Na < 10) and the explanation's assertion of \"volume depletion.\" Option C (HRS) is a plausible distractor but is a diagnosis of exclusion; normally, one must rule out prerenal causes (like lactulose dehydration) first. Since the keyed answer relies on false pathophysiology and the alternative is not definitively established, no option is defensible.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-006", "question": "A 28-year-old pregnant woman at 32 weeks gestation is admitted for severe preeclampsia with BP 170/110 mmHg. She is started on IV magnesium sulfate for seizure prophylaxis and IV labetalol for blood pressure control. One hour after initiation of magnesium, she becomes somnolent, with loss of deep tendon reflexes. Respiratory rate is 8 breaths/min. Serum magnesium level is 9.2 mg/dL. After securing the airway, the most specific immediate treatment is:", "options": ["IV administration of 10% calcium gluconate 1 gram over 10 minutes", "IV administration of furosemide 40 mg to enhance renal excretion", "Immediate hemodialysis", "Discontinuation of magnesium sulfate and administration of IV levothyroxine", "IV administration of pyridostigmine 2 mg"], "answer": "A", "answer_index": 0, "explanation": "Calcium gluconate is the direct antagonist to the life-threatening cardiac and neuromuscular effects of hypermagnesemia. It stabilizes cardiac membranes and reverses respiratory depression caused by magnesium. Furosemide (B) promotes excretion but is not immediate. Dialysis (C) is for severe cases with renal failure but is not the first step after airway management. Pyridostigmine (E) is for myasthenia, not magnesium toxicity.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of iatrogenic magnesium toxicity in a preeclamptic patient, evidenced by loss of deep tendon reflexes, somnolence, respiratory depression (RR 8), and a supratherapeutic magnesium level (9.2 mg/dL). The question asks for the most specific immediate treatment after airway management. IV Calcium gluconate (Option A) is the standard antidote; it competitively antagonizes magnesium at the neuromuscular junction and stabilizes cardiac membranes, providing immediate reversal of respiratory and neuromuscular depression. Furosemide (Option B) can aid excretion but is not the immediate antidote for life-threatening symptoms and requires careful fluid management. Hemodialysis (Option C) is a last resort for renal failure, not the first-line antidote. Pyridostigmine (Option E) is for myasthenia gravis. The item is medically accurate, logically sound, and follows standard guidelines.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of iatrogenic magnesium toxicity in a preeclamptic patient, evidenced by loss of deep tendon reflexes, somnolence, respiratory depression (RR 8), and a supratherapeutic magnesium level (9.2 mg/dL). The question asks for the most specific immediate treatment after airway management. IV Calcium gluconate (Option A) is the standard antidote; it competitively antagonizes magnesium at the neuromuscular junction and stabilizes cardiac membranes, providing immediate reversal of respiratory and neuromuscular depression. Furosemide (Option B) can aid excretion but is not the immediate antidote for life-threatening symptoms and requires careful fluid management. Hemodialysis (Option C) is a last resort for renal failure, not the first-line antidote. Pyridostigmine (Option E) is for myasthenia gravis. The item is medically accurate, logically sound, and follows standard guidelines.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-007", "question": "A 62-year-old man with a history of asbestos exposure 30 years ago presents with unilateral right-sided pleural effusion. Thoracentesis reveals exudative fluid (by Light's criteria) with cytology positive for adenocarcinoma. PET-CT shows FDG-avid right pleural thickening and effusion, with no other distant metastases. The next best step in management is:", "options": ["Systemic chemotherapy with platinum-pemetrexed", "Pleurodesis followed by systemic chemotherapy", "Extrapleural pneumonectomy", "Pleurectomy/decortication followed by adjuvant chemoradiation", "Immunotherapy with pembrolizumab as first-line treatment"], "answer": "D", "answer_index": 3, "explanation": "This describes a likely diagnosis of malignant pleural mesothelioma (given asbestos exposure, unilateral effusion, pleural thickening). For resectable disease (stage I-III) in a fit patient, the standard of care is maximal cytoreductive surgery (pleurectomy/decortication) followed by adjuvant chemotherapy and possibly radiation. Extrapleural pneumonectomy (C) is a more radical, less commonly performed option. Systemic therapy alone (A) is for unresectable disease. Pleurodesis (B) is palliative.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: C (Contradiction)\\nVerdict on keyed answer: No defensible answer (based on text provided)\\n\\nThe stem contains a fatal internal contradiction. It explicitly states that pleural fluid cytology is positive for \\\"adenocarcinoma.\\\" This finding defines the diagnosis as metastatic carcinoma (likely non-small cell lung cancer, Stage IV M1a) rather than malignant pleural mesothelioma. However, the answer key (D) and the rationale treat the patient as having mesothelioma, recommending pleurectomy/decortication. These are mutually exclusive diagnoses; mesothelioma arises from mesothelial cells, not glandular epithelium. For a patient with Stage IV adenocarcinoma presenting with a malignant pleural effusion, cytoreductive surgery (pleurectomy) is not the standard of care; the correct management would be systemic therapy (Option A or E, depending on molecular markers). Because the stated medical fact (adenocarcinoma) contradicts the diagnosis required for the key to be correct, the item is incoherent. \\n\\nMinimal fix: Change \\\"cytology positive for adenocarcinoma\\\" to \\\"cytology consistent with malignant mesothelioma\\\" (e.g., calretinin positive).\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction)\nVerdict on keyed answer: No defensible answer (based on text provided)\n\nThe stem contains a fatal internal contradiction. It explicitly states that pleural fluid cytology is positive for \"adenocarcinoma.\" This finding defines the diagnosis as metastatic carcinoma (likely non-small cell lung cancer, Stage IV M1a) rather than malignant pleural mesothelioma. However, the answer key (D) and the rationale treat the patient as having mesothelioma, recommending pleurectomy/decortication. These are mutually exclusive diagnoses; mesothelioma arises from mesothelial cells, not glandular epithelium. For a patient with Stage IV adenocarcinoma presenting with a malignant pleural effusion, cytoreductive surgery (pleurectomy) is not the standard of care; the correct management would be systemic therapy (Option A or E, depending on molecular markers). Because the stated medical fact (adenocarcinoma) contradicts the diagnosis required for the key to be correct, the item is incoherent. \n\nMinimal fix: Change \"cytology positive for adenocarcinoma\" to \"cytology consistent with malignant mesothelioma\" (e.g., calretinin positive).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-008", "question": "A 40-year-old woman presents with palpitations, heat intolerance, and weight loss. TSH is <0.01 mIU/L, free T4 is 3.2 ng/dL (high). Thyroid ultrasound shows a 2 cm hypoechoic nodule in the right lobe. Radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) with a photopenic area corresponding to the nodule. The most likely diagnosis is:", "options": ["Graves' disease with a coexisting cold nodule", "Toxic multinodular goiter", "Subacute thyroiditis", "Factitious thyrotoxicosis", "Marine-Lenhart syndrome (Graves' disease with a functioning nodule)"], "answer": "A", "answer_index": 0, "explanation": "The diffusely increased uptake is diagnostic of Graves' disease. The photopenic ('cold') nodule within an area of diffusely high uptake indicates a non-functioning nodule, which raises concern for malignancy and requires FNA biopsy. Marine-Lenhart syndrome (E) is Graves' with a *functioning* (hot) nodule. Toxic MNG (B) would show multiple areas of increased uptake. Subacute thyroiditis (C) shows very low uptake.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with thyrotoxicosis and a high radioactive iodine uptake (RAIU) of 45%, which rules out subacute thyroiditis and factitious thyrotoxicosis (both associated with low uptake). The pattern of 'diffusely increased uptake' is the hallmark of Graves' disease. The specific finding of a 'photopenic' (cold) area corresponding to the nodule distinguishes the correct answer from the distractors. Option A accurately describes this scenario: Graves' disease driving the diffuse uptake, with a coexisting non-functioning (cold) nodule. Option E (Marine-Lenhart syndrome) is incorrect because it involves a functioning (hot) nodule within a Graves' gland. Option B (Toxic MNG) typically shows patchy uptake or distinct hot nodules with suppressed background, not diffuse high uptake. The question is medically accurate, logically sound, and tests a clinically significant distinction.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with thyrotoxicosis and a high radioactive iodine uptake (RAIU) of 45%, which rules out subacute thyroiditis and factitious thyrotoxicosis (both associated with low uptake). The pattern of 'diffusely increased uptake' is the hallmark of Graves' disease. The specific finding of a 'photopenic' (cold) area corresponding to the nodule distinguishes the correct answer from the distractors. Option A accurately describes this scenario: Graves' disease driving the diffuse uptake, with a coexisting non-functioning (cold) nodule. Option E (Marine-Lenhart syndrome) is incorrect because it involves a functioning (hot) nodule within a Graves' gland. Option B (Toxic MNG) typically shows patchy uptake or distinct hot nodules with suppressed background, not diffuse high uptake. The question is medically accurate, logically sound, and tests a clinically significant distinction.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-009", "question": "A 50-year-old man with diabetes mellitus and hypertension is found to have a serum potassium of 6.8 mEq/L on routine labs. He is asymptomatic. ECG shows peaked T waves. He is given IV calcium gluconate, insulin/dextrose, and albuterol. His potassium decreases to 6.0 mEq/L. Renal function is normal. Further workup reveals a low serum aldosterone and elevated plasma renin activity. The most likely cause of his hyperkalemia is:", "options": ["Type 4 renal tubular acidosis (hyporeninemic hypoaldosteronism)", "Addison's disease", "Gordon's syndrome (pseudohypoaldosteronism type II)", "Spironolactone use", "Rhabdomyolysis"], "answer": "C", "answer_index": 2, "explanation": "Gordon's syndrome (familial hyperkalemic hypertension) is characterized by hyperkalemia, hypertension, normal GFR, metabolic acidosis, and *suppressed* renin but *normal or high* aldosterone. The key here is the elevated renin, which rules out hyporeninemic hypoaldosteronism (A, which has low renin and low aldosterone) and points to a primary renal defect in potassium excretion. Addison's (B) has low aldosterone and high renin but also has hyponatremia and hypotension.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (No answer defensible). The clinical vignette describes a patient with hypertension, hyperkalemia, low aldosterone, and elevated plasma renin activity. This specific combination of findings (High Renin, Low Aldosterone, Hypertension) is medically incoherent with the provided options. \\n\\nThe keyed answer, Gordon's syndrome (Pseudohypoaldosteronism Type II), is characterized by renal sodium retention leading to volume expansion, hypertension, and consequent suppression of renin (Low Renin) and variable aldosterone. The vignette's statement of \\\"elevated plasma renin activity\\\" directly contradicts the pathophysiology of Gordon's syndrome. \\n\\nOther options are also incorrect: Type 4 RTA (A) presents with low renin and low aldosterone. Addison's disease (B) presents with high renin and low aldosterone but is associated with hypotension and salt-wasting, not hypertension. Spironolactone (D) causes elevated renin and elevated aldosterone levels. \\n\\nThe item likely contains a typo in the stem (intending \\\"suppressed\\\" renin) or represents a fundamental author error regarding the pathophysiology of Gordon's syndrome. As written, no option is correct.\",\"medical_accuracy_score\":\"1\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (No answer defensible). The clinical vignette describes a patient with hypertension, hyperkalemia, low aldosterone, and elevated plasma renin activity. This specific combination of findings (High Renin, Low Aldosterone, Hypertension) is medically incoherent with the provided options. \n\nThe keyed answer, Gordon's syndrome (Pseudohypoaldosteronism Type II), is characterized by renal sodium retention leading to volume expansion, hypertension, and consequent suppression of renin (Low Renin) and variable aldosterone. The vignette's statement of \"elevated plasma renin activity\" directly contradicts the pathophysiology of Gordon's syndrome. \n\nOther options are also incorrect: Type 4 RTA (A) presents with low renin and low aldosterone. Addison's disease (B) presents with high renin and low aldosterone but is associated with hypotension and salt-wasting, not hypertension. Spironolactone (D) causes elevated renin and elevated aldosterone levels. \n\nThe item likely contains a typo in the stem (intending \"suppressed\" renin) or represents a fundamental author error regarding the pathophysiology of Gordon's syndrome. As written, no option is correct.", "medical_accuracy_score": 1, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 1}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-010", "question": "A 65-year-old man with a mechanical aortic valve (On-X) on warfarin presents with a transient ischemic attack. INR on presentation is 1.8 (target 2.5-3.5). He has no bleeding history. The most appropriate adjustment to his antithrombotic regimen is:", "options": ["Increase warfarin dose to achieve INR 2.5-3.5; add aspirin 81 mg daily", "Increase warfarin dose to achieve INR 2.5-3.5; no aspirin needed", "Switch to apixaban 5 mg twice daily", "Add clopidogrel 75 mg daily to current warfarin therapy", "Discontinue warfarin and initiate dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "A", "answer_index": 0, "explanation": "For a mechanical aortic valve, the standard of care is warfarin with a target INR of 2.5-3.5. In patients who have a thromboembolic event despite therapeutic INR, adding aspirin 75-100 mg is recommended. Since his INR was subtherapeutic at the time of the TIA, the first step is to optimize INR control. However, given the event, adding low-dose aspirin is now indicated based on PROACT and other trials. Direct oral anticoagulants (C) are contraindicated in mechanical valves. Dual antiplatelet therapy (E) is inferior to warfarin for valve protection.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe item presents a patient with a mechanical aortic valve and a TIA in the setting of subtherapeutic INR (1.8). The question asks for the most appropriate adjustment. According to ACC/AHA guidelines, aspirin (75–100 mg) is recommended for all patients with mechanical prosthetic valves in addition to warfarin, barring contraindications. Since this patient is not on aspirin and has no bleeding history, adding aspirin (Option A) is the standard of care adjustment, particularly following an embolic event. While the immediate cause of the TIA was likely the subtherapeutic INR, leaving the patient on warfarin monotherapy (Option B) is inferior to the guideline-recommended combination therapy. Option C is contraindicated (DOACs in mechanical valves). Option E is inferior. The item is logically sound and medically accurate in the context of US guidelines. The provided explanation is slightly contradictory (stating aspirin is for events *despite* therapeutic INR, then applying it here where INR was low), but the keyed answer itself is the correct best management step.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe item presents a patient with a mechanical aortic valve and a TIA in the setting of subtherapeutic INR (1.8). The question asks for the most appropriate adjustment. According to ACC/AHA guidelines, aspirin (75–100 mg) is recommended for all patients with mechanical prosthetic valves in addition to warfarin, barring contraindications. Since this patient is not on aspirin and has no bleeding history, adding aspirin (Option A) is the standard of care adjustment, particularly following an embolic event. While the immediate cause of the TIA was likely the subtherapeutic INR, leaving the patient on warfarin monotherapy (Option B) is inferior to the guideline-recommended combination therapy. Option C is contraindicated (DOACs in mechanical valves). Option E is inferior. The item is logically sound and medically accurate in the context of US guidelines. The provided explanation is slightly contradictory (stating aspirin is for events *despite* therapeutic INR, then applying it here where INR was low), but the keyed answer itself is the correct best management step.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]